EICHOR
● Active Not Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Condition: Chronic Kidney Disease · Sponsor: Boehringer Ingelheim
About this study
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication for kidney disease called SGLT2 inhibitor within 1 month before the study or have certain health conditions cannot take part in this study. The purpose of this study is to find out whether a medicine called vicadrostat, used in combination with another medicine called empagliflozin, works in people with chronic kidney disease. In this study, participants are randomly assigned to one of two groups. Participants have an equal chance of being assigned to either group. In one group, participants take the 2 study medicines, vicadrostat and empagliflozin, every day for 3 months. In the other group, participants take placebo and empagliflozin for the first 1.5 months, and then they take vicadrostat and empagliflozin together for the next 1.5 months. The study medicines are taken orally as tablets. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants are in the study for about 4.5 months. During this time, they visit the study site multiple times. Doctors regularly test kidney function by measuring specific proteins in the blood and urine. The results are compared between the two groups to see whether there are differences between starting the study medicines at the same time or one after the other. The doctors also regularly check participants' health and take note of any unwanted effects.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (157)
| Apogee Clinical Research | Huntsville, Alabama, United States | — |
| Orange County Clinical Trials | Anaheim, California, United States | — |
| North America Research Institute | San Dimas, California, United States | — |
| Valiance Clinical Research-Tarzana-68237 | Tarzana, California, United States | — |
| Amicis Research Center - Valencia | Valencia, California, United States | — |
| Focus Clinical Research | West Hills, California, United States | — |
| Clinical Research of Brandon LLC | Brandon, Florida, United States | — |
| Hillcrest Medical Research | DeLand, Florida, United States | — |
| Encore Medical Research | Hollywood, Florida, United States | — |
| Finlay Medical Research Corp | Miami, Florida, United States | — |
| Total Research Group, LLC | Miami, Florida, United States | — |
| San Marcus Research Clinic, Inc. | Miami Lakes, Florida, United States | — |
+ 145 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06926660